Associate Laboratory Director

Experience leading a laboratory offering prenatal screening and evaluating, interpreting, and reporting out NGS and microarray data.

Familiarity with next-generation sequencing, and/or knowledge of advanced methods of copy number detection.

Strong background in human and medical genetics, and oncology with a familiarity of online human genomic databases and variant interpretation resources (e.g., ClinVar, gnomAD, OMIM, ClinGen)

Understanding of statistical measures utilized in genetic testing and screening.

Must be able to discern color visually [or be able to evaluate cellular morphology when applicable] and pass applicable screening assessment

2 or more years of experience in a CLIA-certified clinical laboratory setting analyzing, interpreting and reporting clinical genetic/genomic data.

This range reflects a good-faith estimate of the base pay we reasonably expect to offer at the time of  hire. Final compensation will vary based on experience, qualifications, and internal equity considerations.

This position is also eligible for additional compensation and benefits through Natera’s robust Total Rewards program, including:

Annual performance incentive bonus

Long-term equity awards

401(k) with company match

Review, approve, and sign-out reports for a variety of clinical molecular/cytogenetic and/or oncologic results, including NIPT, carrier screening, PGD/PGS, products of conception and rare disease testing on platforms including SNP array analysis, NGS, and other methodologies.

Oversee the review of genetic and CNV variant data: interpret NGS and microarray results in the context of medical literature, online variant databases and other references along with relevant patient demographic data.

Provide clinical and technical support for genetic counselors and other laboratory personnel.

Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained.

Analyze lab data, contribute to or write publications for high-quality scientific journals.

The Technical Supervisor is responsible for ensuring: appropriate test method selection; adequate method verification to determine the accuracy and precision of the test; enrollment of the laboratory in a CMS-approved proficiency testing (PT) program for the test performed; PT samples are tested in accordance with the CLIA requirements; PT results are returned within the time frames established by the PT program; PT reports are reviewed by the appropriate staff; corrective action plans are followed when PT results are found to be unacceptable or unsatisfactory; quality assessment and quality control programs are established and maintained; acceptable analytical test performance is established and maintained for each test system; remedial actions are taken and documented when significant deviations from the laboratory’s established performance characteristics are identified, and patient test results are reported only when the system is functioning properly; personnel have been appropriately trained and demonstrate competency prior to testing patient specimens; policies and procedures are established for monitoring personnel competency in all phases (preanalytic, analytic, and postanalytic) of testing to assure the ongoing competency of all individuals who perform testing; remedial training or continuing education needs are identified, and training provided; and an approved procedure manual is available to all personnel.